These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1979555)

  • 21. Haloperidol decanoate in the treatment of schizophrenia.
    Zapletálek M; Zbytovský J
    Act Nerv Super (Praha); 1989 Apr; 31(1):39-41. PubMed ID: 2571224
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
    Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
    Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Accidental intravenous administration of haloperidol decanoate].
    Heinz P
    Psychiatr Prax; 1996 Jan; 23(1):42. PubMed ID: 8851235
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study.
    Miller JL; Ashford JW; Archer SM; Rudy AC; Wermeling DP
    Pharmacotherapy; 2008 Jul; 28(7):875-82. PubMed ID: 18576902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depot neuroleptics and manic depressive psychosis.
    Lowe MR; Batchelor DH
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():53-62. PubMed ID: 3559161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
    Lazzarin M; Benati F; Cesario V
    Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
    Lemperiere T; Ropert R; Leger JM; Alexandre JY; Clerc G; Darondel A; Delaunay J; Delteil P; Malauzat D; Raynaud J
    Encephale; 1984; 10(5):217-22. PubMed ID: 6519017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
    Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate.
    Leff JP; Tress KH
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():27-40. PubMed ID: 3559160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
    Vasavan Nair NP; Suranyi-Cadotte B; Schwartz G; Thavundayil JX; Achim A; Lizondo E; Nayak R
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):30S-37S. PubMed ID: 3514689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
    Viala A; Aymard N; Leyris A; Caroli F
    Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
    Pérez C; Stier Rosner SE
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

  • 36. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of haloperidol decanoate on the cardiovascular system.
    Kaneko S; Edwards JG; Goldie A; Fukushima Y; Sato T
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):73-7. PubMed ID: 1684394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed hypersensitivity to a corticosteroid suspension containing methylprednisolone. Two cases of conjunctival inflammation after retrobulbar injection.
    Mathias CG; Robertson DB
    Arch Dermatol; 1985 Feb; 121(2):258-61. PubMed ID: 3977346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
    De Cuyper H; Bollen J; van Praag HM; Verstraeten D
    Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.